Annual report pursuant to Section 13 and 15(d)

Shareholders Equity and Capital Stock (Details 6)

v3.24.0.1
Shareholders Equity and Capital Stock (Details 6) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Outstanding warrants      
Outstanding Beginning Balance, Warrants 16,730,530 24,368,530 22,062,878
Number of warrants, issued 39,100,000   16,930,530
Number of warrants, Exercised (413,030) (7,638,000) (14,050,920)
Number of warrants, Expired     (573,958)
Outstanding Ending Balance, Warrants 55,417,500 16,730,530 24,368,530
Number of shares to be issued upon exercise      
Outstanding Beginning Balance, Number of shares to be issued upon exercise 8,365,265 12,184,265 11,031,439
Number of shares to be issued upon exercise, issued 19,550,000   8,465,265
Number of shares to be issued upon exercise, Exercised (206,515) (3,819,000) (7,025,460)
Number of shares to be issued upon exercise, Expired     (286,979)
Outstanding Ending Balance, Number of shares to be issued upon exercise 27,708,750 8,365,265 12,184,265
Per share exercise price      
Per share exercise price, Outstanding Beginning $ 1.35 $ 1.16 $ 0.90
Per share exercise price, issued 1.50   1.35
Per share exercise price, Exercised 1.35 0.75 0.98
Per share exercise price, Expired     1.00
Per share exercise price, Outstanding Ending $ 1.46 $ 1.35 $ 1.16